Recently FTC, Bureau of Competition leadership opened the GCR Live 7th Annual Antitrust Law Leaders Forum. Using Bureau previous cases and remedy studies, Acting Director, D. Bruce Hoffman, individually supported policy and activities that could impact healthcare and life science company's innovation strategies. Overall, the agency is concerned and will continually focus and act on the threat of elimination to innovation competition that certain mergers between competitors ma